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Coronaviruses in 
Children, Greece
To the Editor: Two recently de-
tected human coronaviruses (HCoVs), 
NL63 and HKU1, increased the num-
ber of coronaviruses known to infect 
humans to 5 (1–3). HCoV-229E and 
HCoV-NL63 belong to antigenic 
group 1, HCoV-OC43 and HCoV-
HKU1 belong to antigenic group 2, 
and severe acute respiratory syndrome 
(SARS)–associated coronavirus 
(SARS-CoV) is most closely related 
to group 2 coronaviruses. In 2005, 
an optimized pancoronavirus reverse 
transcription–PCR assay was used to 
explore the incidence of HCoV-NL63 
infection in children in Belgium who 
had a diagnosis of respiratory tract in-
fection (4). We report the results of an 
epidemiologic study that used a uni-
versal coronavirus RT-PCR assay to 
detect coronaviruses among children 
in Greece with acute respiratory tract 
infections.
We tested throat swab specimens 
obtained from children hospitalized 
in Greece during June 2003 through 
May 2004 (200 children 2 months to 
14 years of age, mean 4.09 years) and 
during December 2005 through March 
2006 (44 children 1.6–8.5 years of 
age, mean 5.05). Specimens were 
obtained the ﬁ  rst day of each child’s 
hospitalization, and all specimens 
were included in the study, regardless 
whether other respiratory microorgan-
isms were detected.
The 25-μL reaction contained 
200  μM dNTPs, 0.2 μM primer 
PC2S2 (equimolar mixture of 5′-
TTATGGGTTGGGATTATC-3′ and 
5′-TGATGGGATGGGACTATC-3′), 
0.8  μM primer PC2As1 (5′-TCAT-
CAGAAAGAATCATCA-3′), 1 μL of 
enzyme mix from the QIAGEN One-
Step RT-PCR Kit (QIAGEN GmbH, 
Hilden, Germany), and 5 μL of RNA. 
The initial 30-min reverse transcrip-
tion step at 48°C was followed by 
10 cycles of 20 sec at 94°C, 30 sec at 
62°C with a decrease of 1°C per cycle, 
40 sec at 72°C; 40 cycles of 20 sec at 
94°C, 30 sec at 52°C, 40 sec at 72°C; 
and a ﬁ  nal extension step at 72°C for 
10 min. To determine the sensitivity 
after optimization, we tested quanti-
ﬁ  ed RNA in vitro transcripts that in-
cluded the natural primer binding sites 
of the respective coronavirus genomes. 
Sensitivities for SARS-CoV, HCoV-
OC43, HCoV-229E, and HCoV-NL63 
were 61.0, 800.0, 8.2, and 82.3 nomi-
nal RNA copies per assay, respec-
tively. A separate test was not done for 
HCoV-HKU1 because it had the same 
primer binding sites as HCoV-OC43. 
A phylogenetic tree based on a 400-bp 
genome fragment of the polymerase 
gene was constructed (online Appen-
dix Figure, available from www.cdc.
gov/EID/13/6/947-appG.htm).
Of 200 samples collected in 
2003–2004, 5 (2.5%) were positive for 
coronaviruses (2 each for HCoV-NL63 
and HCoV-229E and 1 for HCoV-
OC43), and of 44 samples collected 
in 2005–2006, 2 (4.5%) were positive 
for coronaviruses (1 for HCoV-229E 
and 1 for HCoV-OC43) (GenBank ac-
cession nos. EF103180–EF103184, 
EF394298, and EF394299). CoV-
HKU1 was not detected.
The ampliﬁ  ed genome region is 
one of the most conserved regions of 
the coronavirus genome. However, 
sequences for HCoV-NL63 strains 
isolated in Greece are genetically 
closer to the sequence for a strain 
(AY567487) isolated in Amsterdam in 
2003 (1) than to a strain (AY518894) 
from a specimen collected in Rot-
terdam in 1988 (2) (0.6% vs. 1.1% 
nucleotide divergence). Sequences for 
HCoV-229E and HCoV-OC43 strains 
isolated in Greece differ from se-
quences for strains isolated elsewhere 
by 0.5%–1.7%.
The HCoV-NL63–positive speci-
mens in our study were obtained from 
a 9- and a 14-month-old child during 
winter 2003–2004; no cases were iden-
tiﬁ   ed during 2005–2006. Specimens 
positive for HCoV-229E and HCoV-
OC43 were detected during both study 
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periods (Table). HCoV-OC43 affected 
children with a mean age of 3.1 years 
(median, 1.4 years), and HCoV-229E 
affected children with a mean (and 
median) age of 5.5 years. However, 
no general conclusions can be drawn 
from these data because number of 
cases is too few.
None of the patients in Greece had 
an underlying disease, and all recov-
ered completely. Patients infected with 
HCoV-229E had been hospitalized for 
upper respiratory tract infections, and 
those with HCoV-OC43 had lower 
respiratory tract infections; all cases 
were mild. Both children infected with 
HCoV-NL63 had symptoms of lower 
respiratory tract infections: 1 child had 
severe pneumonia and was hospital-
ized for 12 days, while the other had a 
mild course of bronchiolitis. 
HCoV-NL63 was ﬁ  rst identiﬁ  ed 
in Amsterdam, the Netherlands, by 
van der Hoek et al. (1) from a na-
sopharyngeal specimen obtained in 
2003 from a 7-month-old child with 
bronchiolitis, conjunctivitis, and fe-
ver. One month later, Fouchier et al. 
(2) reported the characterization of the 
same virus isolated from a specimen 
collected in 1988. The specimen had 
been obtained from an 8-month-old 
child with pneumonia in Rotterdam, 
the Netherlands. Later, HCoV-NL63 
was detected in 2.5% of bronchiol-
itis patients <2 years of age in Japan 
(5) and in most children hospitalized 
with bronchiolitis in Australia and 
Canada (6,7). 
Coinfection with HCoVs and 
other respiratory viruses is frequently 
observed and is associated with se-
vere clinical syndromes, especially 
in infants and young children (6,8). 
Coinfection was observed in 3 of the 
7 HCoV-positive patients in our study. 
The 3 patients were infected with 
HCoV-OC43 or HCoV-229E; coinfec-
tion with respiratory syncytial virus 
was found in 2 patients, and coinfec-
tion with Mycoplasma pneumoniae 
was found in 1 patient. It was not 
possible to determine the role of the 
HCoVs in these coinfections. In addi-
tion, because coronaviruses can be de-
tected even 3 weeks after an acute epi-
sode, some cases of coinfection might 
represent former rather than current 
HCoV infection (9).
In conclusion, we detected 3 types 
of HCoVs in Greece: 229E, OC43, 
and NL63. This ﬁ  nding provides ini-
tial insight into the epidemiologic 
features of coronaviruses in Greece. 
Further studies are needed to ﬁ  nd the 
exact clinical effect of these HCoVs in 
humans and to elucidate the epidemi-
ology of coronaviruses worldwide.
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Table. Epidemiologic and laboratory data for patients with coronavirus infection, Greece* 
Specimen
no., HCoV 
strain  Age, sex 
Sample
date Symptoms 
WBC
(cells/ mm
3) Granulocytes, %
ESR
(mm/h)
Days in 
hospital Coinfection
10/03, 229E  3 y, F  Jun 3,
2003
Fever (39°C), cough, 
pharyngitis 
10,400 87 40 3 RSV
16/03, 229E  8 y, M  Jun 14, 
2003
Fever (41°C), 
headache, rhinitis, 
sinusitis
18,900 86.4 30 4 ND
109/03, NL63  14 mo, F  Nov 30, 
2003
Fever (39°C), cough, 
severe pneumonia 
18,700 44.0 85 12 ND
173/04, NL63  10 mo, M  Feb 10, 
2004
Fever (38.5°C), 
cough, rhinitis, 
tachypnea,
bronchiolitis
7,100 57.9 55 3 ND
185/04, OC43  17 mo, F  Feb 25, 
2004
Pharyngitis, rhinitis, 
respiratory distress, 
bronchiolitis
10,100 63.2 30 2 ND
12A/06, OC43  6 mo, F  Jan 11, 
2006
Fever (38.8°C), 
cough, tachypnea, 
bronchiolitis
19,950 80.3 35 6 RSV
14A/06, 229E  7.5 y, M  Feb 13, 
2006
Fever (40.5°C), 
cough, rhinitis 
20,600 83.1 98 4 Mycoplasma 
pneumoniae
*HCoV, human coronavirus; WBC, white blood cell count; ESR, erythrocyte sedimentation rate; RSV, respiratory syncytial virus; ND, not detected.LETTERS
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Bartonella DNA in 
Loggerhead Sea 
Turtles 
To the Editor: Bartonella are fas-
tidious, aerobic, gram-negative, facul-
tative, intracellular bacteria that infect 
erythrocytes, erythroblasts, endothelial 
cells, monocytes, and dendritic cells, 
and are transmitted by arthropod vec-
tors or by animal scratches or bites (1–
6). Currently, 20 species or subspecies 
of Bartonella have been characterized, 
of which 8 are known zoonotic patho-
gens (7). B. henselae has been recently 
identiﬁ  ed from canine blood (8) and 
from harbor porpoises (9). Pathogenic 
bacteria are an important threat in ter-
restrial and marine environments, and 
in the case of B. henselae, reservoir 
hosts may be more diverse than cur-
rently recognized. 
The purpose of this study was 
to determine whether sea turtles are 
infected with Bartonella spp. Blood 
samples were obtained from 29 free-
ranging and 8 captive, rehabilitating 
loggerhead sea turtles (Caretta caret-
ta) from North Carolina coastal wa-
ters. Reptilian erythrocytes are nucle-
ated, and commercial lysis methods 
clogged ﬁ  ltration columns because of 
the high DNA content of whole blood. 
Consequently, DNA was extracted 
from frozen whole blood by using a 
modiﬁ  ed alkaline lysis method adapt-
ed from an avian cell culture DNA ex-
traction method (10). PCR screening 
for Bartonella was performed by using 
primers for the 16S-23S internal tran-
scribed spacer (ITS) region (Table). 
Bartonella ITS–positive samples were 
further screened by using primers for a 
consensus sequence of the phage-asso-
ciated gene Pap31 (9). Primers for the 
28S rRNA were used as a housekeep-
ing gene. The PCR-positive control 
contained 0.002 pg/μL of B. hense-
lae H1. Water was the negative PCR 
control. Amplicons of the expected 
sizes were consistently obtained from 
housekeeping gene and positive con-
trol reactions, while amplicons were 
never obtained from negative controls. 
ITS amplicons were obtained from 16 
(43%) of 37 sea turtle blood samples 
tested, including samples from 13 
free-ranging and 3 rehabilitated turtles. 
Pap31 PCR was performed for Bar-
tonella ITS-PCR–positive samples. 
Pap31 amplicons were obtained from 
5 samples of which 3 were success-
fully sequenced. Ampliﬁ  cation  and 
sequencing of the 16S-23S ITS region 
detected 2 Bartonella species: a B. 
henselae–like organisms and 1 more 
similar to B. vinsonii subsp. berkhofﬁ  i. 
The 3 Pap31 amplicons successfully 
sequenced conﬁ  rmed B. henselae in-
fection. Sequences obtained from 1 
sample matched B. henselae strains 
H1-like, the B. henselae SA2-like 
strain, and B. vinsonii subsp. berkhof-
ﬁ  i genotypes II and IV, which sug-
gests that this turtle was co-infected 
with multiple Bartonella spp. and 
strains. Three other samples yielded 
amplicons 99%–100% identical with 
B. henselae strain SA2, and 3 yielded 
sequences most similar to B. vinsonii 
subspecies berkhofﬁ  i genotypes II and 
IV. Two samples contained an ITS 
region sequence most similar to B. 
henselae SA2, but with a 15-bp dele-
tion beginning 617 bases downstream 
from the 16S rRNA gene. Whether 
these ITS sequence differences rep-
resent distinct strains or nonrandom 
translocation events is uncertain.
Four sea turtle blood samples 
contained partial ITS sequences most 
similar to B. vinsonii subsp. berkhofﬁ  i. 
However these amplicons were much 
shorter than expected for B. vinsonii 
subspecies berkhofﬁ  i genotype II and 
genotype IV sequences in GenBank. 
Because Pap31 gene ampliﬁ  cation 
was unsuccessful for these samples, 
it is unclear whether small amplicons 
represent a species related to B. vin-
sonii subsp. berkhofﬁ  i or a new Bar-
tonella sp.
Table. Primers used for PCR amplification 
Primer Sequence
28s s  5′-AAACTCTGGTGGAGGTCCGT-3′
28s as  5′-CTTACCAAAAGTGGCCCACTA-3′
ITS 325s  5′-CTTCAGATGATGATCCCAAGCCTTTTGGG-3′
ITS 1100as  5′-GAACCGACGACCCCCTGCTTGCAAAGCA-3′
Pap 31 1s  5′-ACTTCTGTTATCGCTTTGATTTCRRCT-3′
Pap 31 688(as)  5′-CACCACCAGCAAAATAAGGCAT-3′